Clinical trial
Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
NCT00004686 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 1994
- Completion date
- September 30, 1999
- Enrollment
- 300
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.